Development, validation and application of assays to quantify metrifonate and 2,2-dichlorovinyl dimethylphosphate in human body fluids

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 741, Issue 2, 2000, Pages 257-269

  Heinig, Roland ^a   Zimmer, Dieter ^a   Yeh, Shirley ^b   Krol, George J ^b  

^a BAYER AG   (Germany)

^b BAYER CORPORATION   (United States)

Author keywords

2,2 Dichlorovinyl dimethylphosphate; Metrifonate

Indexed keywords

DICHLORVOS; DRUG METABOLITE; METRIFONATE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; DRUG URINE LEVEL; ELECTRON CAPTURE DETECTION; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ASSAY; SOLID PHASE EXTRACTION; TECHNIQUE;

CALIBRATION; CROSS-OVER STUDIES; DICHLORVOS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INSECTICIDES; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRICHLORFON;

EID: 0034640324     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(00)00125-0     Document Type: Article

References (27)

1. Lamb H.M., Faulds D. Drugs Aging. 11:(6):1997;490.
2. Dedek W., Koch H., Uhlenhut G., Bröse F. Z. Naturforschg. 24b:1969;663.
3. Nordgren I., Holmstedt B. Curr. Res. Alzheimer Ther. 2:1988;281.
4. Morris J.C., Cyrus P., Orazem J., Mas J., Bieber F., Ruzicka B.B., Gulanski B. Neurology. 50:1998;1222.
5. Giacobini E. Keio J. Med. 36:1987;381.
6. McKeith I.G. Dement. Geriatr. Cogn. Disord. 9:(Suppl. 2):1998;2.
7. Villén T., Aden Abdi Y., Ericsson Ö., Gustafsson L.L., Sjöqvist F. J. Chromatogr. 529:1990;309.
8. Shimizu K., Shiono H., Fukushima T., Sasaki M., Akutsu H., Sakata M. Forensic Sci. Int. 83:1996;61.
9. Fournier E., Sonnier M., Dally S. Clin. Toxicol. 12:(4):1978;457.
10. Nordgren I., Holmstedt B., Bengtsson E., Finkel Y. Am. J. Trop. Med. Hyg. 29:(3):1980;426.
11. Nordgren I., Bengtsson E., Holmstedt B., Pettersson B.-M. Acta Pharmacol. Toxicol. 49:(Suppl. V):1981;79.
12. D. Zimmer, C. Müller, unpublished internal report, Bayer AG, 1997.
13. Ameno K., Fuke C., Ameno S., Kiriu T., Ijiri I. J. Anal. Toxicol. 13:1989;150.
14. Aden-Abdi Y., Villén T., Gustafsson L.L., Ericsson Ö., Sjöqvist F. J. Chromatogr. 612:1993;336.
15. Unni L.K. J. Chromatogr. 612:1993;338.
16. Nordgren I., Bergström M., Holmstedt B., Sandoz M. Arch. Toxicol. 41:1978;31.
17. Radiċ B., Eškinja I. Period. Biol. 92:(2):1990;191.
18. Heinig R., Dietrich H., Halabi A. Clin. Drug Invest. 18:(1):1999;35.
19. Commission of the European Communities/CPMP, Note for Guidance: Working Party on Quality of Medicinal Products: Analytical Validation, III/844/87-EN, 1989.
20. US Department of Health and Human Services, FDA/CDER, Draft Guidance for Industry: Bioanalytical Methods Validation for Human Studies, Docket No. 98D-1195, 1998.
21. Unni L.K., Hannant M.E., Becker R.E. J. Chromatogr. 573:1992;99.
22. Unni L.K., Womack C., Hannant M.E., Becker R.E. Methods Find. Exp. Clin. Pharmacol. 16:(4):1994;285.
23. Nordgren I. Fund. Appl. Toxicol. 1:1981;230.
24. Aden Abdi Y., Villén T. Pharmacol. Toxicol. 68:1991;137.
25. Heinig R., Boettcher M., Herman-Gnjidic Z., Pierce C.H. Clin. Drug Invest. 17:(1):1999;67.
26. Heinig R., Sachse R. Int. J. Clin. Pharmacol. Ther. 37:(9):1999;456.
27. Pettigrew L.C., Bieber F., Lettieri J., Wermeling D.P., Schmitt F.A., Tikhtman A.J., Ashford J.W., Smith C.D., Wekstein D.R., Markesbery W.R., Orazem J., Ruzicka B.R., Mas J., Gulanski B. J. Clin. Pharmacol. 38:1998;236.